Free Newsletter
Genetic variants for most type 2 diabetes cases found
An international team of scientists including Professor Philippe Froguel of Imperial College, London has identified a group of genetic variants that they believe can flag the risk of type 2 diabetes in 70 percent of all cases. The research points the way to new genetic tests that will be able to identify most of the population at risk of adult-onset diabetes. Once they are identified, a combination of diet and exercise could head off the disease. Their work could also advance fresh therapies for treating diabetes. One of the genetic variants for SLC30A8 involves the transfer of mineral zinc in the body, which is needed for the production of insulin.
- check out the release
- read the article from the CBC
Related Articles:
Researchers probe chemical link to diabetes cure. Report
Genetic variation key indicator of diabetes risk. Report
Genetic testing advances as insurers balk. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: